SynthesisCurrent cardiology reports2022
AngioVac for Minimally Invasive Removal of Intravascular and Intracardiac Masses: a Systematic Review.
Synthesis in Current cardiology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Percutaneous Vacuum-Assisted Debulking of Infected and Non-Infected Left-Sided Cardiac Masses Using the AngioVac System: A Systematic Review of Published Case Reports and Case Series.Journal of clinical medicine · 2026Review
- Minimally invasive and robotic-assisted excision of intracardiac masses: a single-center retrospective study.Journal of cardiothoracic surgery · 2026Article
- Outcomes and financial comparison of percutaneous debulking versus surgical management of tricuspid endocarditis.Journal of cardiothoracic surgery · 2026Article
- A Multi-Modality Approach to the Assessment of a Right Atrium Mass in a Female Patient with Breast Cancer Undergoing Neoadjuvant Chemotherapy.Diagnostics (Basel, Switzerland) · 2025Article
- Minimally invasive aspiration of thrombi and masses in left-sided cardiac chambers: a comprehensive literature review.Frontiers in cardiovascular medicine · 2025Review
- Novel Mechanical Aspiration Thrombectomy in Patients With Acute Pulmonary Embolism: Results From the Prospective APEX-AV Trial.Journal of the Society for Cardiovascular Angiography & Interventions · 2025Article
- Thrombus vs Tumor: Use of AngioVac in a RV Mass.JACC. Case reports · 2024Article
- Article
- Evidence-Based Update on Transcatheter Therapies for Pulmonary Embolism.Current cardiology reports · 2024Review
- Modern Treatment of Pulmonary Embolism (USCDT vs MT): Results From a Real-World, Big Data Analysis (REAL-PE).Journal of the Society for Cardiovascular Angiography & Interventions · 2024Article
- Percutaneous Intracardiac Mass Extraction in High Surgical-Risk Patients.Journal of medical cases · 2023Article
- Contemporary management of intracardiac thrombi: a tale of two clots.The journal of extra-corporeal technology · 2023Review
- A Rare Case of a Failed AngioVac Procedure Used to Debride Tricuspid Vegetation Complicated by Ogilvie Syndrome.Cureus · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewManagement of intracardiac masses, such as right heart thrombi and catheter-related vegetations, can be challenging. Many patients are high-risk candidates for surgical extraction due to multiple comorbidities and risk of distal embolization. In this review, we highlight the advancements in percutaneous approaches for treatment of intracardiac masses utilizing AngioVac (AngioDynamic, Latham, NY). RECENT
findingsWith the Food and Drug Administration (FDA) approval of the AngioVac System in 2009, a growing body of evidence has proven it to be a feasible and effective tool to extract thrombi and masses from the iliocaval system and the right heart. In this review, we highlight the feasibility of AngioVac System (AngioDynamic, Latham, NY) based on the published cases series and registries. Future randomized controlled trials are needed to establish an algorithmic approach in treating intracardiac masses.
Indexed as
Identifiers
35129741What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.